
Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled...
Essential HypertensionThe purpose of this study is to compare depressor effect and safety between combination therapy with telmisartan plus low-dose hydrochlorothiazide and amlodipine in hypertensive patients.

Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension
HypertensionThe purpose of this study is to evaluate the safety, efficacy, and tolerability of azilsartan medoxomil, once daily (QD), in individuals with hypertension.

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
Diabetes MellitusType 21 moreThis study was designed to evaluate the anti-hypertensive efficacy of lacidipine in hypertensives with Type 2 diabetes and effectiveness on endothelial cell function in Korean population.

Ramipril - Hypertension
HypertensionPrimary objective: Mean values of systolic and diastolic office blood pressure Secondary objectives: Total mortality, occurrence of cardio- and cerebrovascular events, change of mean blood pressure (ABPM : Ambulatory Blood Pressure Monitoring) during the observation

ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)
Pulmonary HypertensionThe primary objective is to determine the effect of ambrisentan on exercise capacity in subjects with PAH.

Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)
HypertensionThe purpose of this study is to establish the safety of clevidipine in the treatment of perioperative hypertension. Approximately 500-900 patients with perioperative hypertension undergoing coronary artery bypass grafting (CABG), off-pump coronary artery bypass (OPCAB) or minimally invasive direct coronary artery bypass (MIDCAB) surgery and/or valve replacement/repair procedures were anticipated to be randomly assigned to one of two treatment groups: clevidipine or nitroglycerin.

Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial HypertensionThe purpose of this study is to assess the safety and tolerability of sorafenib in patients with PAH already on existing therapy with a prostacyclin [epoprostenol (Flolan)], treprostinil (Remodulin), or iloprost alone, or with or without sildenafil (Viagra/Revatio).

The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol...
Pulmonary HypertensionDetermination of the effects of sildenafil citrate and epoprostenol when used in combination in patients with pulmonary arterial hypertension

Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension...
HypertensionHyperlipidemiaTo evaluate the effectiveness of amlodipine/atorvastatin therapy by assessing the percentage of subjects who reach target blood pressure (BP) and LDL-C targets as defined by their governing guidelines.

A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages...
HypertensionDrugs used to treat high blood pressure in adults should also be effective in treating high blood pressure in children and adolescents. This study will test the safety and efficacy of valsartan in treating high blood pressure in hypertensive children 6-16 years of age whose parent(s)/guardian(s) grant permission to participate.